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ABSTRACT
Multilayer microfluidic devices were designed and fabricated such that an array
of different oxygen concentrations could be applied to a testing area in any desired
sequence and with unconstraint application times. The principle of flow resistance
dictates that a large channel length will impose a larger resistance and therefore a larger
reduction in flow rate versus a shorter channel length. To exploit this feature, the
microfluidic device employs a fluidic resistance network composed of an array of pre-
determined variable length channels to generate different oxygen to nitrogen flow rate
ratios, i.e. different oxygen concentrations. Standard lithographic techniques were used to
fabricate the microfluidic devices, using highly gas permeable silicone rubber
(polydimethylsiloxane (PDMS)). The stacked microchannel architecture, channel
dimensions, and layer thicknesses in the device were optimized for rapid diffusion and
saturation of 02 N 2 mixtures into the testing areas. The oxygen concentration was
dynamically monitored using polymeric fluorescence-based oxygen sensors integrated
into the device. By altering oxygen levels over time, this device aims to selectively build
up biofilms on the artificial tooth substrate as the process occurs in-vitro. A study
concerning this application is also presented.
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Title: Professor of Mechanical Engineering
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Chapter 1: Thesis Introduction
Dental plaque is the general term used for the highly complex and biodiverse
microbial community that builds on tooth surfaces. These communities are generally
known as biofilms and are most commonly found in moist or liquid environments
attached to a solid substratum, such as in the oral cavity. Although over 500 bacterial
species comprise plaque, colonization follows a regimented pattern with adhesion of
initial colonizers to the tooth enamel followed by secondary colonization through
bacterial adhesion.[l1] Understanding the conditions that promote colonization and
subsequent biofilm development is particularly important as it plays an important role in
the prevention and treatment of health problems resulting from dental plaque, such as
tooth decay and if left untreated to more serious conditions, such as cardiovascular
disease and pre-term labor.
In the study of dental plaque, in-vivo experimentation is complicated and limited.
Apart from the ethical issues and difficulties involved in sampling collection and access,
plaque's bio-diverse and heterogeneous nature causes much difficulty in controlled
testing. As an alternative, there is a range of in-vitro model systems aiming to mimic the
oral environment to some degree in order to manipulate associated variables.
A critical environmental variable affecting the composition and activity of dental
biofilms, is oxygen concentration. "Exposure of bacteria to oxygen has significant
impacts on sugar metabolism, acid production, stress tolerance, and factors related to
persistence in dental plaque." [2] Additionally, biofilms forming in different surfaces of
the mouth sustain a variety of aerobes, facultative anaerobes, and obligately anaerobic
bacteria, which have different oxygen environmental requirements.
A multilayer microfluidic device capable of generating different oxygen
concentrations over time has been designed and fabricated to address oxygen
concentration effects. Additionally, a study was executed to survey the possibility of
generating different oxygen concentrations in the device and simultaneously sustain the
co-culturing of multiple bacterial species on artificial tooth substrates in vitro. This
device has demonstrated a large potential in the investigated dental plaque application,
and also in other biological micro-device applications.
The microfluidic devices, chips, were made primarily from (polydimethylsiloxane
(PDMS)) cast from silicon wafer molds containing positive-relief channels patterned
using standard lithographic techniques. The integration of a microfluidic platform for
dynamic oxygen sensing and delivery in a flowing medium together with the exploitation
of PDMS's permeability to oxygen, made it possible to help pioneer a microfluidic chip
capable of generating different oxygen concentrations over time in vitro.
This microfluidic device not only creates the array of different oxygen
concentrations, but allows the user to choose the order at which the oxygen
concentrations are applied to the area of study. Nitrogen and oxygen inputs connect to the
device and deliver the gasses into conduits that branch out into channels of different
lengths. Due to fluidic resistance, the flow rate observed in a long channel is lower than
that observed in a short channel having the same cross-sectional area. Therefore a set of
pre-determined variable length channels for oxygen joint with a different set for nitrogen,
grants an opportunity to select a specific combination of these so that when the flowing
gasses come together, a specific oxygen concentration is achieved. To this effect, two
variable length channel networks, VL channel networks, were incorporated. The device
also bears a valve system which controls which combination of channels is selected. The
oxygen concentration in the gas mixture resulting from the VL network equilibrates with
the testing area through a thin PDMS membrane, given the high permeability of PDMS to
oxygen.
In order to test different aspects of the device relevant to its performance, three
different multilayer PDMS chips were created. The first chip, Chip A, consisted of two
layers: a nitrogen/oxygen mixing layer and a valve system stacked above. This chip was
used to test the level of functionality of the valve system and to identify the optimum
working channel width for the VL channels by varying parameters in the soft lithography
fabrication process. A second one-layer chip, Chip B, was designed and fabricated to test
the accuracy of the oxygen concentrations created by the VL channel combinations.
Using an LED - based optical excitation and detection system the oxygen content in the
microfluidic chip was monitored in real time. The final chip, Chip C, was designed and
fabricated for the purposes of studying biofilm formation, specifically to selectively build
up biofilms on an artificial tooth substrate located in the bacteria culture layer by
dynamically imposing an array of oxygen concentrations.
Chip C's design is intended for the co-culturing of multiple bacteria species
present in dental plaque. But in order to induce biofilm formation, the model system
needs to be realistic; aiming to mimic the environmental conditions of plaque ecosystems
during experiments is critical. A method for artificial saliva preparation and periodic
supply of sucruose, i.e. meals, to replicate nutrient conditions, is presented. Also an
artificial tooth substrate exhibiting the characteristic of tooth enamel is suggested to serve
as the solid substratum for biofilm formation. Information is also provided on
recommended bacteria to be cultured and tested in the device. Finally, preliminary
experiments conducted by Raymond Lam, testing the optimal oxygen conditions for uni-
cultures grown in microfluidic devices in-vitro are discussed.
A more detailed account of dental plaque and the importance of its study is
provided in chapter two, along with the analysis of the underlying problem being
addressed and previous relevant research. Presenting a brief description of this realm of
research, the evolution of the thesis objectives, and the ground work for dissertation will
communicate the building blocks for a better understanding of the thesis. Chapter three
outlines the theoretical work performed in the design, fabrication, and testing of the
microfluidic devices and its application to the study of dental plaque. Chapter four
follows a detailed account of the experimental procedures performed in the fabrication
and testing of the devices and a description of possible subsequent dental plaque
experiments. The results of the experiments and a respective analysis can be found in
chapter five, along with concluding remarks.
Chapter 2: Groundwork for Dissertation
Dental plaque develops naturally as part of the host's defense system against
exogenous microorganisms. Due to oral hygiene in humans and natural defenses the
attachment, growth, and removal of bacteria in the oral cavity is a dynamic and
continuous process. These multi-species microbial communities are generally known as
biofilms and are highly structured with complex physiology and metabolic activity. The
heterogeneous environment allows for wide variety of microorganisms to grow, thrive,
and survive in the presence of one another, even if the organisms are generally
incompatible. Group interactions can be beneficial or antagonistic to some of the
interacting populations. Among some interbacterial interactions observed in biofilms are
synergism, competition, antagonism, and environmental effects.
Dental Plaque Models
Difficulties with in-vivo studies along with the complexity of dental plaque have
led to the development of a variety of laboratory biofilm plaque model systems. For these
models to be effective in explaining plaque ecology and pathology, they must be realistic
and encourage the behavior which is under investigation.[3] These systems differ in the
technologies employed, their strengths and limitations, and their uses due to the
inevitable compromises between the in vivo ecosystem and the simplification and control
needed to gain useful results.
Aspects of Dental Plaque Relevant to Models
Many aspects of dental plaque come into play when trying to model it in-vitro.
The biofilm of linked bacterial communities are complex and heterogeneous, site-
specific, varied, evolving, yet spatially organized. The microbiota is biodiverse
experiencing microbial succession, the presence of interspecies structures, and the
formation of microcolonies and clonal booms.[3] The environment is also uncontrollable,
with fluctuating laminar flow fluids and the distinct, changing, interacting
physcochemical gradients in the intraplaque surroundings that differ from the general oral
environment.[3] Also contributing are the counter forces to plaque formation such as host
immunological chemical defenses, fluid shear, abrasion, and oral hygiene procedures. [3]
Other Dental Plaque In-Vitro Techniques
Among the major oral biofilm culture systems are chemostat-based systems,
growth rate controlled biofilm fermenter (GRBF), artificial mouths, the constant -depth
film fermenter (CDFF), and the multiplaque artificial mouth. All these have distinctive
features and approaches to modeling the oral environment.[3] For instance, chemostats
have a controlled fluid environment and a planktonic phase with a nutritionally limited
growth-rate. [3] In artificial mouths, unrestrained growth is usually observed, although,
liquid shear plays a small part in limiting size.[3] When compared with chemostat
systems, artificial mouths lack planktonic phases and are less controlled by the physical
properties of the oral fluids. [3] In the positive sense, they have more flexibility,
properties such as PH are controllable, and nutrient cycling which imitates meals are
possible. These systems have their strengths, limitations, and varying applications, but
they all lack in the control of the dynamic oxygen concentration in the biofilm
environment.
Aspect of Dental Plaque Relevant to the Microfluidic Device
Oxygen is a vital environmental factor affecting the composition, build-up, and
activity of dental plaque biofilms. Biofilms found on tooth surfaces are composed of
aerobes, facultative anaerobes, and anaerobic bacteria regardless of the rich oxygen
environment in the oral cavity. "Not surprisingly, oral bacterial biofilms have relatively
active oxygen metabolism and have developed defenses against the presence of oxygen
and a wide variety of redox environments. "Notably, exposure of bacteria to oxygen has
significant impacts on sugar metabolism, acid production, stress tolerance, and factors
related to persistence in dental plaque." [2]. The development of biofilms follows a
regimented pattern with adhesion of initial colonizers, mediated by specific or non
specific physico-chemical interactions. Suitable conditions lead to proliferation and the
formation of microcolonies. With environmental changes comes secondary colonization,
through bacterial adhesion, beginning the formation of a multispecies community.
Studying the effect of changing oxygen concentrations on biofilm formation among other
aspects of dental plaque would be a beneficial study, with the potential to shed light on
biofilm formation.
Oxygen Concentration Control - Current Techniques
Among some of the current procedures for specific oxygen concentration
exposures is the culturing of bacteria in the desired oxygen concentration environment
and then transferring the media while trying not to perturb the given environment.
An impressive work on oxygen concentration gradients was conducted by
Jaehyun Park et al. They created a microsystem containing an array of multiple
microelectrodes capable of creating accurate, consistent, and superimposed oxygen
gradients. Water electrolysis was the means to generate the controlled amounts of
dissolved oxygen from an array of noble metal microelectrodes embedded in silicone
microchannels.[4] This method however is not suitable for providing dynamically
changing oxygen concentrations, unless the array of microelectrodes was made mobile.
Oxygen Concentration Control - Concurrent Work:
Raymond H. Lam is an MIT PhD candidate with previous and ongoing work on
the generation of differential dissolved oxygen concentration for biological cell cultures
in-vitro. He has successfully cultured the following dental plaque bacteria, A.viscosus and
S. mutans, using the microfluidic oxygenator and has acquired estimates for the optimum
oxygen growth conditions for these bacteria. He was a mentor for this project along with
Prof. Todd Thorsen, heading the "Mouth-On-A-Chip" project working towards a
microfluidic device for the co-culturing of multiple bacterial species to study biofilm
formation and tooth decay under a dynamically changing oxygen environment, among
other environmental factors.
Oxygen Concentration Control - Thesis Project
The main objective of the microfluidic devices fabricated was to generate an array
of different oxygen concentrations applicable to a testing area within the device to
simulate the constantly changing oxygen environment in the oral cavity. The device
allows for the user to choose any of the oxygen concentrations and decide the order at
which these are applied in vitro to the area of study.
The device works by manipulating nitrogen and oxygen input flows such that
mixtures with different proportions of these gasses and therefore different oxygen
concentrations are created. Manipulating the resistance by varying channel length is a
means to control the gas flow rate. An array of pre-determined variable length channels
were incorporated into the device, one for the nitrogen input and a different array for the
oxygen input. As the gasses flow through channels they experience resistance imposed by
fluid flow decreasing the flow rate at which the gas travels through the channel. The
election of a specific combination of an oxygen channel and a nitrogen channel results in
a corresponding oxygen concentration. A valve system was used to control which
combination of channels was selected in order to expose the test area to the specific
oxygen concentration of choice.
The stacked chip architecture was designed such that the testing area would be
located below the nitrogen/oxygen gas flow channel and separated by a thin PDMS
membrane. The permeability of PDMS to oxygen permitted the nitrogen:oxygen mixture
to saturate the level located below the gas channel, exposing the test area to the oxygen
concentration induced by the valve system. In a biofilm application of this device, the
artificial tooth substrate located in the testing channels and the medium fluid flowing
through it would be exposed to the same oxygen concentration in the mixer channel
above.
Oxygen Sensing - Previous work
The monitoring of the oxygen concentration inside the microfluidic device is due
to the development of an integrated microfluidic platform for dynamic oxygen sensing by
Adam P. Vollmer, Ronald F. Probstein, Richard Gilbert, and Todd Thorsen. This group
developed a platform for real-time sensing of dissolved oxygen in a microfluidic
environment using an oxygen-sensitive luminescent dye. They showed that the integrated
oxygen sensor in the membrane-based micro-oxygenator device produced accurate
results across a range of tested flow rates, 0.05 -5 mL/min. [5] The incorporation of this
platform onto the biofilm microfluidic devices was possible given the flexible
configuration and its ease of fabrication.
Chapter 3: Theory
Microfluidic Device Design and Components:
Three different sets of PDMS chips were created. The first two sets, Chip A and
Chip B, were experimental versions constructed to optimize different parameters
pertaining to the functionality of the third and final PDMS chip, Chip C.
Chip A was used to identify the optimal width for the variable length channels
and to test the functionality of the valve system by varying parameters in the soft
lithography fabrication process. Different soft lithography parameter settings affect
different aspects of the final product. For instance, spin coating speed determines layer
thickness and PDMS preparation parameters influence material properties. In addition,
PDMS chips were made with three different widths to test for the optimum working
channel width for the VL channels.
Chip A consisted of two layers: the nitrogen/oxygen mixing layer and a valve
system layer. The valve system controls which variable length channel is opened for the
nitrogen input and for the oxygen input. Fabrication consisted of two soft lithography
procedures and plasma bonding to seal the exposed bottom layer channels to a glass slide.
Figure 1:
Experimental Chip A [Two Layers]
*No Bacteria Culture Layer
Bottom Layer: Nitrogen/Oxygen Mix Layer
* Oxygen and Nitrogen Channels
* Mixing Channel




Chip B tested the accuracy of the oxygen concentrations created by the VL
channel combinations. An LED - based optical excitation and detection system was used
to examine the oxygen content in the microfluidic chip. The optical oxygen detection was
achieved through the excitation of PtOEPK, a luminescent dye located in the oxygen
sensing compartments.
Figure 2:
Experimental Chip B [One Layer]
* No Bacteria Culture Layer
* No Nitrogen/Oxygen Valve Control Layer
Bottom Layer: Nitrogen/Oxygen Mix Layer
* Oxygen and Nitrogen Channels
* Mixing Channel
* Oxygen Sensor Compartments
Chip B consists of only one layer containing three different test areas. For each,
the oxygen and nitrogen input ports split up into the variable length channels and feed
into the mixing channels and oxygen sensor compartments. Flow occurs from the small
crosses towards the large cross in all the fabricated chips. Fabrication consisted of a
single lithography procedure, oxygen sensor preparation, and plasma bonding to seal the
microchannels onto a glass slide.
Chip C was designed in the form of a three layer structure. The bottom layer is the
bacteria culture layer made up of a bacterial compartment containing an artificial tooth
substrate and two inlets, one for artificial saliva and one for the growth media. Stacked
above is the nitrogen/oxygen mixing layer with the VL channel network and mixing
channel feeding into the exposure compartment. This exposure section is located right
above the bacteria culture compartment where a thin PDMS film separates the two. Gas
diffusion occurs from the nitrogen/oxygen exposure compartment (middle layer) through
the thin PDMS film into the bacteria culture compartment (bottom layer). Finally, the
third and top layer contains the valve system controlling fluid flow in the middle layer.
The fabrication consisted of three lithography procedures, oxygen sensor preparation,
artificial tooth substrate incorporation, and plasma bonding.
Figure 3:
CHIP C [Three Layers]
Bottom Layer: Bacteria Culture Layer
* Bacteria Culture Area (Testing Area)
* Teeth Simulations
* Flow Channel
Intermediate Layer: Nitrogen/Oxygen Mixing Layer
* Oxygen and Nitrogen Channels
* Mixing Channel
* N/O area over bacterial culture area
* Support Columns
* Oxygen Sensor Compartment
Top Layer: Nitrogen/Oxygen Valve Control Layer
* Valve System
Oxygen and Nitrogen Delivery and The Valve System
A valve system was designed and implemented to control fluid flow in the
nitrogen/oxygen mixing layer such that a single nitrogen feed and a pre-selected
corresponding oxygen feed are opened at any point in time or alternatively the fluid flow
is completely halted. These specific combinations of open feeds generate different ratios
of oxygen to nitrogen flow rates which create the array of desired oxygen concentrations.
There are two inputs: the oxygen and the nitrogen input. A single input channel
breaks up symmetrically to become eight input channels which then feed into the variable
length channel network. Only the two channels specified by the valve operations will
experience fluid flow through the corresponding VL channels.
The following is a schematic of the valve system implemented in the microfluidic
chip.
-
Figure 4: Schematic of valve system used to control fluid flow for 16 vertical flow
channels allowing two open channels simultaneously.
This devices exploits the microfluidic equivalent of a combinatorial multiplexer
by addressing a large number of valves with a small number of connections. The
individual control lines contain a series of valves. When these control lines are
pressurized, the valves are actuated and push down against the channels. N horizontal
control lines control N!/(N!/ 2)2 vertical flow lines.[6] The device was designed to have a
single valve system control both the nitrogen and oxygen channels simultaneously with
control lines grouped into sets of complementary valve groups such that two channels,
instead of one, are opened at a time. Therefore 16 vertical flow channels called for only 5
horizontal control lines. The algorithm defining the activation of the different
combination of control lines is presented in Appendix A.
Variable Length Channel Network
This microfluidic device works on the principle of flow resistance, larger channel
lengths impose a large resistance on the flowing gas causing the gas's flow rate to
decrease. Controlling the amount of resistance the gas experiences, controls the flowrate
at which the gas travels.
Each channel in the network has a different length pattern resulting in a unique
resistance. Different resistance ratios correspond to different flow rate ratios of nitrogen
to oxygen. When a nitrogen feed is opened along side an oxygen feed the different
resistances allow for a specific oxygen to nitrogen ratio to be achieved.
Determination of Volumetric Flow Rate and Fluidic Resistance
Equivalent resistance circuits were used in the microfluidic calculations, where
Ohm's law and Kirchhoff Rules are applicable. The analogous fluidic model is as
follows: hydrodynamic flow resistance corresponds to electric resistance, the flow
velocity corresponds to electric current, and the pressure drop over a channel is
equivalent to the voltage drop across a wire. The flow resistance was calculated in a
similar fashion to that used in electric circuit theory.
Ohm's Law applied to microfluidics generates an equation relating resistance, flow
rate, and pressure drop. Navier Stokes simplifies into a relation for fluid velocity, which
when integrated over the cross-sectional area, results in the volumetric flow rate. An
equation for channel resistance results, when this flow rate is substituted into the
microfluidics version of Ohm's law.
Using Kirchoff Rules, the pre-set pressure and the calculated resistances were used
to determine the final flow rates. To reduce error in the final gas flow rate and VL
channel resistance calculations, the channels preceding the VL channels were designed to
have a resistance at least one order of magnitude lower.
System: Characterization ofFlow
The direction of fluid movement through the microchannels is defined as the x
direction and the flow is modeled as steady, parallel, and one dimensional pressure driven
flow. The one dimensional parallel flow assumption is valid, given that the velocity
components in the y and z direction are small compared to fluid velocity through the
channel. The Reynolds numbers, ratio of inertial forces to viscous forces, calculated for
the VL channels ranged from 0.006 to 0. 015, below the critical value of Re = 1; therefore
the flow is considered laminar.
Navier-Stokes Equation
The Navier-Stokes equations, derived form viscous surface force, stress/strain
constitutive equations, and Newton's second law of motion, provides the equation of
linear momentum for an incompressible viscous fluid,
p- =-VP + pI +V2. (1)Dt
For a one-dimensional system in the x-direction, the equation is as follows:
S a V y  v aPx (a2v a2va a2v_\+
v_+ vx 8v Bv, +P V ++ 2 ay2 +2
a t x -Y a z x ~X x2 )
The time derivative term on the left hand side is eliminated given that the flow is steady,
all non-linear terms are also eliminated since the flow is laminar, and the gravity term
drops as gravity effects are negligible. Also, since the flow is considered to be fully
developed, solutions should only depend on the x-coordinate setting. For this particular
flow in the x-direction, the Navier-Stokes equation reduces to
a2v= 1 dP (3)
ax2  1u dx
where v is the velocity of the flow and 4 is viscosity. The pressure gradient across the
channel is constant for a steady state and was substituted as - AP/l where 1 is the length
of the channel and AP is the pressure difference.
Integrating equation (3) twice results in the following relation
1 dP x24)
vx = 1 -- - + CIx + C2 " (4)
Applying the "no-slip" boundary conditions:
vx =Oaty=0 and vx =0 at y=h, (5)
the velocity distribution becomes
h2 dP x 2
v 4. 2 -- 1 . (6)
8 p [dx( h2
Derivation of Volumetric Flow Rate Equation (Resistance Equation):
For a rectangular channel with width w, height h, and w > h, the volumetric flow rate is
calculated by integrating the velocity over the cross sectional and results in
w-h' dP 1192 h
12p dx z' -W
(7)
Applying electric circuit theory, specifically the equivalent of Ohm's Law, the volumetric
flow rate is written as:
1APQ =AP (8)
R I
R is the specific resistance and I is the length of the channel. The total resistance over the
channel is Rt = Rl. Therefore the previous equation becomes
- AP = RQ. (9)
Combining equations (9) and equation (7), the following is obtained for fluidic resistance
1 w-h3  192-hh
R 12p.1 y;r' w
(10)
Resistance Ratio:
The ratio of resistances is analogous to the ratio of flow rates. Given the same
input pressure for both the nitrogen and the oxygen,
- AP~ = Rt Q. and - APo = Reo Q, (11)
the pressure drop across both systems is approximated as equal. Equating the pressure
drop through the nitrogen and the oxygen channel, the following relation is obtained.
R- QN (12)
Re Q0
where the ratio of resistances is equal to the ratio of flow rates.
Determination of channel lengths ratios:
Specific oxygen and nitrogen channel length combinations were determined using
the resistance equation to obtain the resistance ratio needed for a specific oxygen
concentration. First, an oxygen channel length with its respective calculated resistance
was selected, and then iterations were executed to obtain the corresponding nitrogen
channel length. A matlab program, included in Appendix B, was used to solve the
resistance equation for these purposes. The channels in all the chips were 20 Pn in
height. The variable length channels in Chip B were 40 upm in width. The following chart
contains the oxygen and nitrogen channel lengths, the corresponding resistances, the
resistance ratios, and the measured concentration percentages for Chip B.
Oxygen Oxygen Nitrogen Nitrogen Resistance % p/Po
Channel Channel Channel Resistance Ratio
Length Resistance Length Length
19.58 mm 2.1946*10A13 9.08 mm 8.7851*10A12 5/7 69.03
6.09 mm 6.8260*10^12 3.50 mm 3.3863*10^12 2/3 61.13
11.30 mm 1.2666*10^13 13.00 mm 1.2578*10^13 1/2 47.09
Table 1: Table of corresponding variable channel length to variable channel resistance
and expected oxygen concentration.
The same information for Chip C can be found in Appendix A, along with the valve
system control algorithm.
Mixing Channel
Once the two gases pass through the channel network, they reach the mixing
channel with the desired flow rates. The nitrogen and oxygen undergo diffusion and
advection as they flow through the mixing channel.
Scaling Analysis
Transport equations can be difficult to solve directly for many real systems. The
complexity of a system can be significantly reduced by addressing the notion that
inherent spatial and time scales of a system constrain its behavior.[7] The comparison of
processes using a single common scale provides a simple way to identify dominant or
negligible processes. Applying dimensional reasoning, time and spatial scales can be
determined and used to identify and predict the effects, significance, and order of
magnitude of different system behaviors or parameters.
Fluid Transport
Mass transport occurs through a combination of advection and diffusion.
Advection is the translation of the mass from one region to another. Diffusion, on the
other hand, is the random and spontaneous net movement of particles from an area of
high concentration to an area of low concentration. The mixing channel's purpose relies
on diffusion for passive mixing. Therefore, the diffusive contribution to mass transport
must dominate in comparison to advection, in order for the moving mass to become well
mixed. Scaling analysis was done in order to obtain estimates of an appropriate mixing
channel length.
Scaling the Transport Equation
The diffusive and advective processes are additive and independent. When the
total flux in the x direction including the advective and Fickian diffusion term is
combined with conservation of mass, the advective diffusion equation results:
aC
-+ V (uC)= DV2C. (13)
at
For the mixing channel, a two-dimensional system is considered in an x-y
coordinate system where the time derivative term on left hand side vanishes given that
the flow is steady. The length of the channel is defined as L and the width as w.
Substituting the velocity in the x-direction as u and the velocity in the y-direction as v, the
transport equation becomes
ac ac a2C a2C
u-+v- = D +D . (14)
ax ay a2X a2y
In order to determine which process, if any, dominates, the magnitudes of the terms in the
transport equation are compared by rewriting them in dimensionless form. First a2 /a2x
is eliminated, given that the flow in the x direction is considered constant and then
dimensionless variables were substituted as follows
UC . aC* VC acC* DC a2 C*
-u +-  V (15)L ax w ay W 2 a2y*
where the dimensionless distance is x* = x / L , the dimensionless concentration is
C* = C / C , the dimensionless x-component velocity is u* = u / U, and the
dimensionless y-component velocity is v* = v / V . Equation 15 can further be divided
byDC/L2 to arrive at the dimensionless equation which generates the Peclet number. For
the purposes of this analysis, the comparison between the advection term in the x-
direction and the diffusion term in the y-direction suffices and is of interest. Setting up a
comparison between the dimensionless constants preceding the derivative terms, the
following realation of the advection and diffusion term results
U D
- << • ,  (16)1 w
In order for mixing to occur, the diffusion term has to be much larger than the advection
term. Substituting in the mixing channels dimensions and maximum expected velocity,
the minimum length required for the gas mixture to be well mixed is approximately
0.5mm.
The maximum velocity was calculated by modeling the entire channel
configuration preceding the mixing channel using electric circuit theory. The equivalent
resistance, flow rate, and pressure drop circuit was submitted to Ohm's law and
Kirchhoff Rules, such that the flow rate at the beginning of the mixing channel was
calculated. Given the cross sectional area of the channel, the flow rate was converted to
velocity. In order to obtain the maximum velocity, the two shortest variable length
channels were used in the calculation since they impose the smallest resistance.
Testing Area Exposure to Oxygen Concentrations
PDMS has one of the largest permeability coefficients of polymers to oxygen
which makes it an ideal material for the purposes of this microfluidic chip. After the gas
mixture flows through the mixing channel, it reaches the exposure compartment. The
exposure compartment lies above the testing compartment; the two are separated by a
thin PDMS film. Diffusion between the two layers occurs readily from the exposure
compartment to the testing compartment. The convective mass transfer model mentioned
in the previous section was used to characterize the mass transfer properties of the gas
mixture in order to validate the appropriateness of the microfluidic design.
In order to guarantee a saturated bacterial compartment, the length at which the
concentration boundary layer becomes fully developed must be much lower than the size
of the compartment or the relative time scale of diffusion should be much lower than that
of advection. The later can be assessed through the Peclet number, a dimensionless
number which compares advection and diffusion measuring the ratio of the advective to
diffusive mass transport, specifically the ratio of the advective and diffusive time scales.




If Pe <<<1, diffusion dominates. The area of the compartments is very large in
comparison to that of the channels preceding and following it therefore the velocity of the
fluid when flowing through the compartment is considerably lower than when flowing
through the smaller channel areas. The Peclet number is clearly below I and therefore
diffusion dominates.
Oxygen Sensing
A polymeric fluorescence-based oxygen sensor was integrated into the micro-
channels. This sensor is an LED - based optical excitation and detection system capable
of monitoring the oxygen concentration in the microfluidic chip. Oxygen detection is
achieved through the excitation of the luminescent dye, Pt octaethyl-porphyrin-ketone
(PtOEPK). This particular chemical was chosen not only because it exhibits an
absorption peak of 590nm in the visible spectrum and therefore high-intensity yellow
LEDs can be used for excitation, but also because the dye has an emission peak at 760nm,
which is detectable by Si photodiodes. [5] It also exhibits long-term photostability.[8]
The Stern-Volmer equation for luminescent intensity describes the oxygen
fluorescence quenching process observed in luminophores, in this case PtOEPK.
Collisions between oxygen molecules and fluorophores in excited states lead to a non-
radiative transfer of energy. The degree of fluorescence quenching relates to the
frequency of these collisions and as a result is indicative of concentration, pressure, and
temperature of the oxygen-containing media.[9] The Stern-Volmer equations for
luminescent intensity are as follows
o =1+ Ks [02]=1+ Ks pO2  (18)I
Where I0 is a reference value in the absence of oxygen and KS and KG, are the Stern-
Volmer constants for solution and gas, respectively.
The optical electrical apparatus for dynamic oxygen sensing used to monitor
oxygen content in the microfluidic chip consisted of a yellow LED (590nm, 2500mcd,
Ledtronic) placed over a sensor pad with a BG39 Schott glass (CVI Laser) filter in
between. The Si photodiode (S2386-44k, Hamamatsu) was located below the sensor and
was shielded with an RG715 Schott glass long-pass filter. To amplify and filter the
photodiode current signal, analog electronics were used. The signal was recorded in real





Figure 5: Schematic of the oxygen sensing apparatus displaying major components:
LED, Bandpass Filter, PDMS chip with PtOEPK dye applied, Longpass Filter,
Photodiode and the PC/DAQ.
Characteristic parameters are as follows: maximum sensor resolution varies
between 120 ppb across a range of dissolved oxygen concentrations ranging from 0 to
42.5 ppm and the integrated oxygen sensor was accurate across a wide range of tested
flow rates (0.05 - 5 mL/min). [5]
Plaque Bacteria and Experiment Theory
Bacterial Coagregation
"Coaggregation is a process where genetically distinct bacteria become attached
to one another via specific molecules." [1] The adhesions have been shown to be highly
specific and are typically mediated by adhesins proteins on one cell and saccharide
I
receptors on the other. [1] A current model of biofilm development is that successions of
adhesion and multiplication events take place on the solid surface during formation.
It is thought that there are two ways coaggregation takes part in biofilm
formation. One way is that single cells suspended in the moist or fluid environment,
known as planktonic cells, specifically recognize genetically different cells on the
developing film and adhere to them through coadhesion. Another form is that single cells
coagregate while in suspension and then recognize and adhere to the developing film,
also through coadhesion. [13,14] Within the oral cavity, both types are believed to be
crucial for a regimented succession of bacterial adhesion events. This pairing of bacterial
species within dental plaque result in mutually shared beneficial effects.[12]
Initial colonization of the pellicle on the tooth surface takes place predominantly
by streptococci and gram-positive rods, followed by secondary colonization with gram-
negative filamentatious anaerobes. [11,15] It has been found that primary colonizers can
coaggregate with each other, but usually not with secondary colonizers. Although an
exception to this accepted notion is Porphyromonas gingivalis, a secondary colonizer,
which can coaggregate with Steptoccoccus gordonii, a primary colonizer. [11]
Fusobacterium nucleatum is a secondary colonizer unable to coaggregate with itself. It is
believed to be a bridge organism, because it can coaggregate with both primary and
secondary colonizers. [10] It has also been found that anaerobic secondary colonizers
need to be coaggregate to F. nucleatum in order to survive in the planktonic state.[1]
Chapter 4: Experimental Procedure
This chapter addresses the experimental work performed in the fabrication and
testing of the three microfluidic devices described in chapter 3, Chip A, B, and C,
followed by a description of potential procedures in the application of the device to study
dental plaque biofilm formation.
Fabrication and Testing of Chip A
Chip A consists of two layers: the VL channel network layer and valve system
layer above it. The valve system controls which channel is opened at the nitrogen input
side and at the oxygen input side. The gases flow through these channels, meeting at the
mixing channel entrance and continuing on through the chip. The purpose of this
microfluidic device was to test the functionality of the valve system and to identify the
optimal channel width for the VL channels.
Fabrication of Silicon Wafer Molds for the Microfluidic Chips
Photolithography techniques, used in the fabrication of the silicon wafer molds,
consist of these main steps: wafer cleaning, photoresist application, soft baking, mask
alignment, exposure and development, and hard baking.
In the first step the silicon wafers were cleaned using acetone, methanol, and
isopropanol in order to remove particulate matter on the surface of the wafer, which
could decrease adhesion between the photoresist and the silicon wafer. There are two
types of photoresist: positive and negative. When a negative resist is applied to a silicon
wafer and undergoes exposure to UV light, the resist in the exposed areas becomes
polymerized and more difficult to dissolve. Therefore exposed areas remain on the
surface of the wafer, while the unexposed areas are removed by developer solution. The
positive resists behave in the opposite manner.
SU-8(10) photoresist, a negative resist, was used to fabricate the silicon wafers
used in the casting of the microfluidic chips. The resist was spin coated onto the wafer at
an initial speed of 750rpm and then ramped up to a speed of 150 rpm for 40 s to achieve
the desired thickness of 20 um, characteristic thicknesses at different spin speeds were
found in the MicroChem Corp website.
In the next step, soft baking, the wafer was baked for 3 min at 65 " C and for 7
min at 95 ' C to remove any remaining solvent, to stabilize the film, and induce the
photoresist coating to become photosensitive. Particular care was taken with the baking
time, given that over baking degrades photosensitivity by reducing developer solubility or
destroying portions of the sensitizer and under baking prevents light from reaching the
sensitizer.
For the mask alignment, the mask was aligned with the wafer such that the pattern
was transferable onto the wafer surface. Transparency masks of the valve system and VL
resistance network, inverse of the pattern to be transferred, were prepared using adobe
illustrator and sent to Mikacolor Corp. for printing. An individual mask was then aligned
with a 3' silicone wafer and placed in a UV-light microscope. The exposure method used
was contact printing where the resist-coated silicon wafer was brought into physical
contact with a glass photomask. This contact during exposure allowed for very high
resolution, although problems could result from trapped debris. The exposure time was
120 s. The wafer was then placed on a 65 o C hot plate for 1 min and then on a 95 9C
hotplate for 3 min; the post-exposure bake continues the polymerization process. To
develop the film, PM acetate, a developer, was spin coated on to the wafer at over 200
rpm. Finally the silicon wafer was baked for 2 hrs to harden the photoresist and improve
adhesion of the photoresist to the wafer surface.
Fabrication of PDMS microfluidic device [Chip A]
As mentioned in chapter 1, Chip A consists of the VL network and the valve
system. The valve system PDMS layer was cast using soft lithography techniques,
followed by slightly different techniques for the VL network channel PDMS layer.
Fabrication of Valve System PDMS Layer
Optically-transparent silicone rubber (polydimethylsiloxane (PDMS)), was used
for the casting of the microfluidic chips. PDMS is a two component heat - curing system;
when exposed to heat, the polymer hardens by cross linking of polymer chains.
Preparation consisted of mixing the curing agent and the base at a 1:10 ratio,
respectively, in a double axis centrifuge for 4 min. The mixture was then poured onto the
silicon wafer template contained within a petridish, placed in an excicator under vacuum
for 15 min for degassing, and then in an 800C oven for 2 hrs. Curing at 800C makes the
stamp shrink close to 2%. To account for the shrinking factor, the masks were scaled by
1/102. After baking, the stamp was pealed off from the template and it contained the
channel configuration molded into it. A blade was used to cut the edges of the chips and a
Harris Uni-Core - 0. 75 hole puncher was used to punch holes through the chip at the
input terminals of the valve control lines.
Fabrication of the Varaible Length (VL) Channel Network PDMS Layer
To prepare the middle VL channel network layer, a similar stamp procedure was
followed. After mixing and degassing, the PDMS was spin coated onto the silicon wafer,
instead of being poured, at 2100rpm for 50 s to obtain a thickness of 40 pm. The wafer
was then allowed to stand for 15 min while the PDMS settled and was then baked for 10
min. The baking time for this step was monitored closely, given that over baking and
under baking would compromise the proceeding step, alignment. Under baking causes
excessive stickiness which makes alignment handling very difficult and damage to the
channel area likely. On the other hand, the adherence to the valve system layer weakens
if the PDMS hardens too much in over baking.
In order to attach and align the two layers correctly, a light microscope was used
to aid in the magnification of the area to be aligned. The PDMS chip was then baked for
an hour, pealed off, and holes punched in at the indicated input and output terminals. The
chip was cleaned with isopropanol and dried with nitrogen gas to remove debris. Finally,
it was covered with scotch tape for protection until the next step.
To seal the exposed channel configuration of the VL channel network, bottom
layer, was plasma bonded onto a glass slide using a plasma preparation chamber. Both
the PDMS chip and the glass slide were placed in the plasma preparation chamber with
the channel etchings of the PDMS facing upward. The vacuum was activated until a
pressure of 750 atm was reached and then the oxygen supply was turned on at a medium
setting for 30 s. The PDMS chip was then carefully placed on the glass slide and baked
for at least 6 hrs or overnight. In the plasma preparation chamber, oxygen atoms are
incorporated onto the PDMS surface making the PDMS hydrophilic and inducing the
adherence between the micro-channel side of the stamp and the glass slip through strong
ionic bonds.
Testing of PDMS microfluidic device (Chip A)
Parameters in the soft lithography fabrication process of Chip A were varied in
order to observe valve performance and to optimize the valve system. Ensuring complete
contact at valve restriction sites upon activation is important because incomplete contact
leads to gas leakage which compromises the attainment of the target oxygen
concentration.
Testing the Valve System in the PDMS Microfluidic Device
To test the functionality of the valve system, two parameters in the soft
lithography fabrication process were varied: the RPM spin coating speed and the PDMS
curing agent to base ratio. Five different RPM spin coat settings were used to make chips,
as the rpm is increased the thickness decreases. The thinner the valve layer the easier for
the valves to push down when activated, but layers too thin are susceptible to breakage,
failure, and flaccid behavior. The chips were placed under a light microscope while the
valve lines where activated to view the contact area of the restriction site. Activation
consisted of filling the valve lines with fluid using a syringe or the Harvad syringe pump
system.
Another parameter tested was the base to curing agent ratio. A larger ratio
resulted in a gummier final texture of the cured polymer. Chips were made with the
regular 1:10 ratio and a 1:20 ratio. The chips were placed under observation in the light
microscope while valve activation took place to observe the effect of these changes on
contact area.
Testing the VL channel Width in the PDMS Microfluidic Device
Once an optimized valve system was devised, the optimal channel width for the
VL channels was studied. The VL network was designed with three different channel
widths settings: 20, 40, and 50gmn, 20 pn being the minimum recommended working
width. Characteristics under observation were the performance of the chip, the PDMS
spin coating effects on layer integrity, and silicon wafer channel deterioration/continuity.
A light microscope was used to study the resulting chips and the silicon wafers after each
fabrication cycle, since flawed silicon wafers can lead to difficulties in bonding and
proper valve line inflation. Chip A proved useful in determining the optimum design
specs for the valve system and VL channel width.
Fabrication and Testing of Chip # B
Chip B consisted of only one layer, the VL channel network layer. This chip was
designed to test the oxygen concentrations resulting from the variable length channel
combinations. The fabrication and testing procedures for Chip B are as follows.
Fabrication of PDMS microfluidic device [Chip B]
The fabrication followed the same soft lithography techniques used for the valve
system PDMS layer described in the previous section. The PDMS base and curing agent
were prepared at a 1:10 ratio and poured onto the silicon wafer set inside a Petri dish. It
was degassed and then baked for two hours.
To measure the oxygen concentration created by the variable length channel
combinations, the oxygen-sensitive luminescent dye was incorporated onto the chip. A
print out of the VL channel network layer, containing a schematic of the location of the
dye compartment with respect to the other layer components, was placed under the glass
slide to indicate where the sensor dye had to be applied. The PtOEPK dye was prepared
by dissolving I mg of the dye in 1 mL of 5% polystyrene in toluene. [5] The dye solution
was then applied on the glass slide using a small pipette. A thin layer of the luminescent
dye remained after the evaporation of the solvent and the edges were scratched off using
a blade such that an appropriate sized square film remained. Acetone was used to clean
the corners given that it has a negligible effect on the integrity of the dye.
This chip required no valve control or bacterial culture layer, therefore, the
plasma boding step followed. The PDMS stamp and the glass slide with the PtOEPK dye
were bonded in the plasma preparation chamber to enclose the channels following the
same procedure described in the previous section. The chips were then baked over night.
The Optical Electrical Apparatus for Dynamic Oxygen Sensing:
An LED - based optical excitation and detection system was used to monitor
oxygen content in the microfluidic chip. A yellow LED (590nm, 2500mcd, Ledtronic)
was placed over a sensor pad with a BG39 Schott glass (CVI Laser) filter in between. A
Si photodiode (S2386-44k, Hamamatsu) was placed below the sensor and was shielded
with an RG715 Schott glass long-pass filter. To amplify and filter the photodiode current
signal, analog electronics were used. The signal was recorded in real time along with the
reference LED signal using a USB DAQ card (PDM-1608FS, Measurement Computing).
[5]
Testing for Oxygen Concentration
Oxygen/Nitrogen Input
In the oxygen and nitrogen delivery scheme, gas tanks were connected to the
microfluidic device using 20G steel tube segments connected to Tygon tubing, which in
turn were connected to a syringe pump (Harvard Pump 11, Harvard Apparatus), which
provided a constant flow rate to the device. The gas flow into the chip was controlled by
valves located on the syringes.
Oxygen Concentration Calibration and Measurement Procedure
Once the chip was connected to the nitrogen and oxygen delivery system, it was
set up in the oxygen sensing apparatus. The PtOEPK dye film on the chip under study
was placed below the LED. The offset error in the device was measured by blocking the
sensor from the LED. This reading was subtracted from all future measurements to
account for the error.
Calibration procedures for luminescent intensity versus oxygen concentration
were performed by obtaining the measurements for the 0% and 100% oxygen references
values. To provide these values, pure nitrogen and oxygen gas were separately allowed to
flush the system for a minimum of 10 min, in order for the system to stabilize, and then
measurements taken.
Using the Stern-Volmer Equation for luminescent intensity and the two reference
points, the Stern-Volmer constant and a calibration curve for the detection of oxygen
concentration were obtained. This process was repeated for each of the microfluidic
devices tested and in the case of Chip B, for all three of the PtOEPK films located on the
microfluidic device. To obtain measurements, the nitrogen and oxygen gasses were
flowed through the system at an input pressure of lOkPa. A minimum flowing time of 10
min. was carried out and any additional time needed for the sensor reading to equilibrate.
Using the calibration curve the m Vreadings were converted to oxygen concentration
measurements.
Fabrication of Chip C and Procedures Specific to Device Application
Chip C consisted of three layers: the bacteria culture layer, nitrogen/oxygen
mixing layer, and the valve control layer. This chip is aimed at selectively building up
biofilms on artificial tooth substrate located in the bacteria culture layer by dynamically
imposing an array of oxygen concentration.
Fabrication of Valve System and Nitrogen/Oxygen Mixing PDMS Layer
The fabrication consisted of three lithography procedures, an oxygen sensor
preparation, artificial tooth substrate incorporation, and plasma bonding. The same valve
control and nitrogen/oxygen mixing layers used in Chip A were used on Chip C.
Therefore the fabrication processes used are described in the Chip A fabrication section.
After the preparation and alignment of the layers, the chip was baked for an hour, input
and output holes were punched into the chip, and finally the chip was cleaned by washing
with isopropanal, drying with nitrogen gas, and covering with scotch tape.
Fabrication of Bacteria Culture Silicon Wafer
AZ 50XT photoresist, a positive resist, was used to fabricate the silicon wafers
used in the casting of the bacterial culture layer of the microfluidic chips. This fabrication
process was used because the longer heating times produces a more stable surface profile
and double coating with resist can have a larger effective area. This was needed, given
the nature of the bacterial culture layer design which included a relatively large
compartment area for the bacterial co-culturing.
For a positive resist, the resist exposed to UV light changes the chemical
structure such that it becomes more soluble in the developer. The exposed resist is
removed by developer solution. Transparency masks of the bacteria culture layer
containing an exact copy of the pattern which would remain on the wafer was prepared
using adobe illustrator and sent to Mikacolor for printing.
AZ 50XT adhesion promoter was first spin coated on a chemically cleaned silicon
wafer at an initial speed of 500 rpm and then ramped up to 2100 rpm for 30 s. The spin
speed of 2100 rpm was preferred given that bubbles can be removed by high ramping
speeds. The resist-coated wafer was then baked at 95 o C for 2 min and then at 115 O C for
12 min. A 45 min delay time was carried out before the exposure to allow the wafer to
cool. It was then exposed without a filter to UV light for 8 intervals of 20 s and finally
developed for 15 min.
Fabrication of Bacteria Culture PDMS Layer
Using the silicon wafer prepared for the bacterial culture layer, the addition of the
third layer onto the microfluidic chip followed. This layer was fabricated following a
similar procedure to that used for the oxygen/nitrogen mixing layer. Previously prepared
PDMS (1:10 curing agent to base ratio) was spin coated onto the silicon chip at 2100rpm,
after which a 15 min settling time was allowed. The PDMS covered silicon wafer was
baked for 10 min and then aligned with the previously prepared two layer chip using a
light microscope. After baking for an hour, the chip was ready for holes to be punched
out at the input and output terminals.
Finally, the chip was cleaned in order to proceed to the plasma bonding between
the glass slide and the PDMS chip, which followed the same procedure described for
Chip A. The final chip was then baked overnight.
Preparation for the Co-culturing of Bacteria in the Microfluidic Device
Artificial Saliva Preparation
Mimicking the environmental conditions of plaque ecosystems to the highest
degree possible is critical in order for the model system to realistic and predict behavior
present in-vivo. Nutrient conditions present in the oral cavity were simulated by the
preparation and delivery of artificial saliva. The artificial saliva, basal medium mucin
(BMM), prepared was based on the basal medium of Glenister et al. (1988). The
ingredients were as follows: 0.5% Trypticase peptone [5g/L] (BBL, Becton Dickinson,
MD); 1.0% Proteose peptone [ 10g/L] (Oxoid, Unipath, Basingstoke, UK); 0.5% yeast
extract [5g/L] (Difco Laboratories, Detroit, MI); 0.25% KCl [2.5g/L]; 5mg/L hemin; 1
mg/L menadione; and 0.25% pig gastric mucin (BDH) [2.5g/L] (type III; Sigma Chemical
Co., St Louis, MO). The suggested artificial saliva delivery is 3.6 mL/h to each bacterial
exposure area. [17]
Artificial Tooth Substrate Incorporation
Ninety-six percent of enamel, the outer surface of teeth, is made mainly of
mineral, the primary one being hydroxyapatite. [16] Artificial teeth substrates can be
prepared by combining ~5mg of hydroxyapatite and lmL solution of 5% polystyrene in
toluene.
Bacteria: Cultivation Methods and Procedures
The following bacteria Porphyromonas gingivalis, Prevotella intermedia,
Fusobacterium nucleatum subsp. Polymorphum, Actinomyces viscosus and Steptococcus
mutans can be obtained through ATCC, The American Type Culture Collection. Product
information sheets for the five bacterial organisms are provided in Appendix C. These
sheets include the ATCC medium ingredients and preparation procedure, the growth
conditions needed, biosafety level, and propagation procedure. The bacteria requiring
anaerobic growth conditions can be cultured using a BBL Gas Pack Anaerobic System,
Becton Dickinson.
Chapter 5: Results, Discussion, and Conclusion
Valve System Optimization
Two system parameters in the lithography fabrication process for the valve system PDMS
layer were varied in order to verify the functionality of the valves.
Spin Coating RPM
Batches of Chip A were fabricated using a range from 2100rpm to the 2900rpm
spin coat speed. High rpm results in thinner layers which are more easily deformed when
the valves are activated but may lack in strength. Low rpm results in thicker layers which
are more difficult to displace. The maximum speed setting yielded the best restriction site
contact area of all the devices, but still failed to achieve full contact from valve
activation. In the following diagrams valve performance is shown for the respective spin





Figure 6: Sample valve activation for different spin coat speeds used in the fabrication










PDMS Curing Agent to Base Ratio:
Increasing the PDMS curing agent to base ratio, results in a gummier texture after
curing which aids in valve inflation. All the valves presented in Figure 6 were prepared
using a 1:10 ratio. None exhibited complete contact. The 1:20 PDMS ratio combined
with a spin coat speed of 2300rpm resulted in a final valve layer exhibiting complete
contact. The following figure displays the activated working valve.
Figure 7: Valve activation for Chipl: fabricated using a spin coating speed of 2300 rpm
and using a 1:20 PDMS curing agent to base ratio.
Working Channel Width for Variable Length Channel Network
The nitrogen and oxygen gasses experience fluidic resistance through all the
microchannels in the device. The resistance experienced by the variable length channels
has to be at least an order of magnitude larger than that of the preceding input channels in
order to be considered negligible in comparison. Increasing the relative difference in
surface area between the VL channels and input channels tackles this issue, since a
smaller the cross sectional area leads to a larger fluidic resistance.
The initial VL channel width of 0.02 mm caused a number of problems with the
silicon wafer and the continuity of the channels. In multiple chips the 0.02mm channels
displayed breaks in the channel as seen in the following figure.
Figure 7: Variable length channel width of20 microns. Discontinuity in the channel is
observed in both chips.
Channel widths of 0.04mm and 0.05mm were tested as an alternative and both gave
continuous channels in various iterations and no incongruities in the channels were
observed. A width of 0.03mm was not tested because of its proximity to 0.02mm; a
channel width that guarantees channel continuity is desired. Figure 8 demonstrates
images of both working channel widths.
Figure 8: The left image displays a variable channel width of 40 microns and the right
image displays a variable channel width of 50 microns. No discontinuity is observed in
either chip.
Oxygen Concentration Results and Discussion
The Stern-Volmer equation, describing the oxygen quenching process occurring
in luminescent dyes,
S= 1+K pO2  (18)
I
was used to measure the oxygen concentrations the devices produced. Each oxygen





KsV, was determined through this process. By measuring the luminescent intensity of
two known oxygen concentrations, the 0% and 100% oxygen concentration reference
values, a calibration curve was constructed were the slope corresponded to the Stern-
Volmer constant, the x-axis to normalized partial pressure values, and the y-axis to the
normalized measured luminescent intensity values. A sample calibration curve for the
resistance channel combination producing a 50% oxygen concentration mixture is shown
below.
Figure 9: Stern-Volmer calibration curve for the detection of gaseous oxygen in a 50%
oxygen concentration environment. The slope represents the Stern-Volmer constant for
gas in this particular calibration procedure.
The normalized measured luminescent intensity values plotted in the respective
calibration curve was used to determine the corresponding oxygen concentration, which
resulted to be 47.01% in this case. For the tested oxygen concentrations of 33%, 50 %,
66%, and 77%, the measured and expected concentration values are displayed in graph
below.
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Figure 10: Graph of expected and measured oxygen concentration obtained from four
different combinations of variable channel lengths.
Larger errors are observed at larger oxygen concentration due to the increased
role of temperature and pressure vs. concentration effects on the number of collisions in
the quenching process. Measured results for oxygen concentration varied ±10 in of the
expected value.
This error in part is due to a number of factors including the truncation error in the
USB DAQ card (D1-194RS, DATAQ Instruments), which has a resolution of 10-20m V.
Also the calibration's sensitivity to the 100% oxygen reference value and measurement
equilibration time. A 10 mV change in the measured reference value translates to an
average 2.2% change in the oxygen concentrations measured. Given that measurement
equilibration varied ± 30m V, an error as large as ± 8% oxygen concentration can be
expected, partly explaining the observed ±10 oxygen concentration range.
Lam's uniculture experiments show optimum oxygen concentration ranges for the
two bacteria to be quite large about the optimum value as shown in Figure 11. The
channel numbers represent a seventh fraction with channel 1 corresponding to 0 oxygen
concentration, channel 2 to (1/7) conc., channel 3 to (2/7) conc. and so forth. For the A.
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viscosus, a 40% to 65% growth rate is observed between 42.85 % and 100% oxygen
concentration with the optimum value at 87.50 % 02 concentration. For the S. mutans
the optimum 02 conc. is observed at 42.85% and the range for a 10% to 20% growth rate
is between 28.57% and 71.42%. The microfluidic device presented in this thesis would be
able to target oxygen concentrations well within these ranges. Although, further testing
on the accuracy of the method employed in this device would shed more light in its
aptitude for these biofilm formation applications.
Percentage Growth of A. viscosus and S. mutans






1 2 3 4 5 6 7 8
Channel
Figure 11: Raymond Lam 's uniculture experiment results. Numbering of channels
in the x-axis correspond to (0, 1/7, 2/7, 3/7, 4/7, 5/7, 6/7, and 7/7) oxygen concentrations.
The y-axis represents the % growth observed in both bacteria under these oxygen
environments. Percentage growth was obtained by bacteria counting.
Results are ambiguous as to if the device contains enough accuracy to tackle the
biofilm formation feat to reveal useful results. An approach to improve the oxygen testing
to further test the accuracy of the device would be to use phase detection instead of
luminescent intensity to measure the oxygen concentration. The phase base approach of
luminescent lifetime is beneficial given that the lifetime is an intrinsic property of the
PtOEPK molecule. This would eliminate the possibility of error associated with the
intensity of incident light or differences in dye thickness or distribution. [5]. The
luminescent intensity approach is susceptible to significant measurement errors when
small changes in alignment of the sensor pad occur.
Concluding Remarks
This device design could allow for the regulation of oxygen levels in bacteria
growth media flowing through the lower level channels, dynamically altering the
conditions over time in the testing area. But the experimental results presented are
ambiguous as to if the device contains enough accuracy to generate useful and accurate
results. The current chip design in the Lam uniculture experiments provides an array of
constant oxygen concentrations to individual testing areas. Further testing of the method
presented for dynamic oxygen concentration control in-vitro is valuable given the
potential benefits of using this method for the Lam dental plaque investigation, but also
for a range of Lab-On-A-Chip applications and experimentation of cell behavior.
Appendix A
Variable Channel Lengths, Corresponding Resistances, and Expected
Oxygen Concentrations [Chip C]
Oxy. Conc. Oxy Length Oxy Res. Nit. Length Nit. Res.
83.33% 960*10^-5 107.60*10^11 220*10^-5 21.285*10^11
71.40% 1942*10^-5 217.67*10^11 910*10^-5 88.044*10^11
66.67% 610*10^-5 68.372*10^11 350*10^-5 33.863*10^11
62.50% 810*10^-5 90.79*10^11 560*10^-5 54.181*10^11
41.17% 700*10^-5 78.460*10^11 1150*10^-5 111.26*10^11
44.44% 500*10^-5 56.046*10^11 730*10^-5 70.629*10^11
50.00% 1130*10^-5 126.66*10^11 1300*10^-5 125.78*10^11
Channel Valve Configuration [Chip C]
Oxygen
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Appendix B: Matlab Sript for Resistance Calculations
Resistance Calculation for Oxygen and Nitrogen
clear all;
% Air
% kinematic viscosity: 1.511e-5 [m^2/s]
% density: 1.205 [kg/m^3]
% viscosity: 1.73e-5 [Ns/mA2]
% Water
% kinematic viscosity: le-6 [m^2/s]
% density: 1000 [kg/m^3]










for i = 0:1000,




Appendix C: ATCC Product Information Sheets for Bacteria




Type strain. Purifed genomic DNA of thi straln is
available as ATCCO 251751W".
CITATION OF STRAIN:
If use of this strain results in a scientific publication it
should be cited in that manuscript in the following manner:
Streptococcus mtans ATCCO 25175".
ATCC MEDIA:
#44 Broth: Brain Heart Infusion (BD 237500)
#44 Agar: Brain Heart Infusion Agar (BD 241830) or,
#260 Agar: Tryptic Soy Agar (BD 236950) with





Appropriate safety procedures should always be used with
this material. Laboratory safety is discussed in the following
publicatio: Biosnfety in Microbiologlcal and Biomedical
taboratories, 4th ed. HHS Publication No. (CDC) 93-8395.
J.S. Depatment of Health and Human Services, Centers for
Disease Control and Prevention. Washington DC: US.
Government Printing Office; 1999. The entire text is available
online at www.cdc.ov/od/ohs/biosftvbmbl4/bmbi4to. .
ATCC WARRANTY:
The viability of ATCC products is warramnted for 30 days
from the date of shipment. If you feel there is a problem with
this product, contact Technical Services by phone at 800-638-
6597 or 703-365-2700 or by e-mail at techCa .omr. Or you
may contact your local distributor.
DISCLAIMERS:
This product is intended for laboratory research purposes
only. It is not intended for use in humans.
While ATCC uses reasonable efforts to include accurate
and up-to-date information on this product sheet, ATCC makes
no warranties or representations as to its accuracy. Citations
from scientific literature and patents are provided for
informational purposes only. ATCC does not warrant that such
information has been confinnrmed to be accurate.
This product is sent with the condition that you are
responsible for its safe storage, handling, and use. ATCC is not
liable for any damages or injuries arising from receipt and/or
use of this product. While reasonable effort is made to insure
authenticity and reliability of strains on deposit, ATCC is not
liable for damages arising from the misidentification or
misrepresentation of cultures.
Please see the enclosed Material Transfer Agreement
(MTA) for further details regarding the use of this product.
The MTA is also available on our Web site at www.atcc.ra.
PROPAGATION PROCEDURE:
1. Open vial according to enclosed instructions.
2. Using a single tube of #44 broth (5 to 6 ml), withdraw
approximately 0.5 to 1.0 ml with a Pasteur or 1.0 ml
pipette. Rehydrate the entire pellet
3. Aseptically transfer this aliquot back into the broth tube.
Mix well.
4. Use several drops of the suspension to inoculate an agar
slant and/or plate.
5. Incubate all tubes and plates at 370C for 24-48 hours.
NOTES:
On #44 plates, two colony types may be seen: a) small,
rough, irregular, white; and b) small, smooth, translucent.
Additional information on this culture is available on the
ATCC web site at www.atcc.or
REFERENCES:
1. Coykendall AL. Proposal to elevate the subspecies of
Streptoccus muans to species status, based on their
molecular composition. Int. J. Syst. Bacteriol. 27:26-30,
1977.
2. Skerman VB, McGowan V, Sneath PH. Approved lists of
bacterial names. Int. J. Syst. Bacteriol. 30:225-420, 1980.
Q ATCC, 2005. All rights reserved.
ATCCe is a registered trademark of the American Type Culture
Collection.
Updated (10/05) MVB/SAL
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If use of this strain results in a scientific publication it
should be cited in that manuscript in the following manner.
Actinomyces viscosus ATCC 19246".
ATCC MEDIA:
#44 Broth: Brain Heart Infusion (BD 237500)





Appropriate safety procedures should always be used with
this material. Laboratory safety is discussed in the following
publication: Biosafety in Microbiological and Biomedical
Laboratories, 4th ed. HHS Publication No. (CDC) 93-8395.
U.S. Department of Health and Human Services, Centers for
Disease Control and Prevention. Washington DC: U.S.
Government Printing Office; 1999. The entire text is available
Pnline at www.cdc.gov/odohs/biosftvbmbl4/bmbl4toc.htm.
ATCC WARRANTY:
The viability of ATCC products is warranted for 30 days
from the date of shipment. If you feel there is a problem with
this product, contact Technical Services by phone at 800-638-
6597 or 703-365-2700 or by e-mail at cja"a.torg. Or you
may contact your local distributor.
DISCLAIMERS:
This product is intended for laboratory research purposes
only. It is not intended for use in humans.
While ATCC uses reasonable efforts to include accurate
and up-to-date information on this product sheet, ATCC makes
no warranties or representations as to its accuracy. Citations
from scientific literature and patents are provided for
informational purposes only. ATCC does not warrant that such
information has been confinnmed to be accurate.
This product is sent with the condition that you are
responsible for its safe storage, handling, and use. ATCC is not
liable for any damages or injuries arising from receipt and/or
use of this product. While reasonable effort is made to insure
authenticity and reliability of strains on deposit, ATCC is not
liable for damages arising from the misidentification or
misrepresentation of cultures.
PROPAGATION PROCEDURE:
I. Open vial according to enclosed instructions.
2. Using a single tube of #44 broth (5 to 6 ml), withdraw
approximately 0.5 to 1.0 ml with a Pasteur or 1.0 ml
pipette. Rehydrate the entire pellet.
3. Aseptically transfer this aliquot back into the broth tube.
Mix well.
4. Use several drops of the suspension to inoculate a #44
agar slant and/or plate.
5. Incubate the tubes and plate in an atmosphere of 5% C02
at 37*C for 48 to 72 hours.
NOTES:
Mature colonies are circular, convex, entire, off white,
and opaque. This strain also grows well under anaerobic
conditions.
Additional information on this culture is available on the
ATCC web site at www.atcc.org.
REFERENCES:
I. Mycopathologia 1:81-87, 1938.
2. Gerencser MA, Slack M. Identification of human strains
of Actinomyces viscosus. Appl. Microbiol. 18:80-87,
1969. PubMed: 4896106
3. Georg LK, Pine L, Gerencser MA. Actinomyces viscosws
comb. nov. A catalase positive, facultative member of the
genus Actinomyces. Int. J. Syst Bacteriol. 19;291-293,
1969.
4. Z. Augenheilkd. 79:477-510, 1932.
O ATCC, 2005. All rights reserved.
ATCC• is a registered trademark of the American Type Culture
Collection.
Updated (2/05) ASISAL
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Type strain. Deposited as Wolinella recta.
CITATION OF STRAIN:
If use of this strain results in a scientific publication it
should be cited in that manuscript in the following manner:
Campylobacter rectus ATCC" 33238".
ATCC MEDIA:
#1539 Broth: Modified Chopped Meat Medium
with Formate and Fumarate (see below)
#260 Agar: Tryptic Soy Agar (BD 236950) with
5% Defibrinated Sheep Blood
Ground beef (fat-free) 500.0 g
Distilled water, 1.0 L
IN NaOH, 25.0 ml
Mix meat, water and NaoH and bring to a boil with stirring.
Cool to room temperatre, skim fat from surface and filter,.
retaining both meat partides and filtrate To fJltrate~ add
saicient distiled water to restore volume to 1.0 L To this
filtrate, add:
ypticase (BD 211921), 30.0 g
'east extract, 5.0 g
K2HPO,4, 5.0 g
0.025% Resazurin, 4.0 mi
Agpr (fdsrired), 20.0 g
Boll and cool medium under 80% N2-10% Hr2-10 CO. and
add:
Cysteine HCIH2 0, 0.5 g
Hemin Solution (see below), 10.0 mi
Vitamin K, Solution (see below), 02 ml
Adjust medima for final pH 7.0. Anaerobically dispense 7 ml
medium into tubes containing meat partices (1 part meat to 5
pans luid untder the same gas phase.
Vitamin K, Solution:
Vitamin KI, 0.15 ml
95% Ethanol, 30.0
Store solution in brown bottle under refrigeration




Distilled water to 100.0 ml
Autoclave at 121PC for 15 minutes.
Prepare a solution containing sodi•n formate and fmaric acid
at a concentration of 6% each, austhe p th  to 7.0 andfilter-
sterilize. Prior to inoculation add 0.25 ml to a tube containing
pp imately 5 ml ofthe medium described above
CONDITIONS:
Temperature: 37*C
Atmosphere: Anaerobic gas mixture,
80% Nr-lO% COrI10% H2
BIOSAFETY LEVEL: 1
Appropriate safety procedures should always be used with
this material. Laboratory safety is discussed in the following
publication Biarbfety in Microbiological and Biomedical
Laboratories, 4th ed. HHS Publication No. (CDC) 93-8395.
U.S. Department of Health and Human Services, Centers for
Disease Control and Prevention. Washington DC: U.S.
Government Printing Office; 1999. The entire text is available
online at www.cdc.gav/od/ohs/biosfty/bmbl4/bmbl4toc.hrn.
ATCC WARRANTY:
The viability of ATCC products is warranted for 30 days
from the date of shipment. If you feel there is a problem with
this product, contact Technical Services by phone at 800-638-
6597 or 703-365-2700 or by e-mail at ahh ._c.g. Or you
may contact your local distributor.
DISCLAIMERS:
This product is intended for laboratory research purposes
only. It isnot intended for use in humans.
While ATCC uses reasonable efforts to include accurate
and up-to-date information on this product sheet, ATCC makes
no warranties or representations as to its accuracy. Citations
from scientific literature and patents are provided for
informational purposes only. ATCC does not warrant that such
information has been confmed to be accurate.
This product is sent with the condition that you are
reponsible for its safe storage, handling, and use. ATCC is not
liable for any damages or injuries arising from receipt and/or
use of this product. While reasonable effort is made to insure
authenticity and reliability of strains on deposit, ATCC is not
liable for damages arising from the misidentification or
misrepresentation of cultures.
Please see the enclosed Material Transfer Agreement
(MTA) for further details regarding the use of this product.
The MTA is also available on our Web site at www.atcc.org.
PROPAGATION PROCEDURE:
1. Supplement medium to be used with formate and
fumarate solution.
2. Open vial according to enclosed instructions.
3. Under anaerobic conditions, withdraw 0.5 ml of #1539
Amerian Type Culture Collection
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broth from a single test tube (5 to 6 ml) and rehydrate the
entire vial contents.
4. Aseptically transfer this aliquot back into the broth tube.
Additional broth can be inoculated using 0.2 ml of this
cell suspension per tube. A slant and a pre-reduced blood
plate may also be inoculated with 0.1 ml each of the cell
suspension. An aerobic blood plate may also be streaked
to check for purity.
5. Incubate tubes and plate under anaerobic conditions at
37*C. Incubate second #260 plate aerobically at 370 C.
6. Within three to seven days, growth should be evident by
slight turbidity and some sediment in the broth. Pinpoint
translucent colonies will be formed on the anaerobic #260
plate. Some spreading occurs with additional incubation.
NOTES:
Three colony types may be seen: a) 1 mm in diameter
convex variant; b) agar-pitting or corroding variant up to 5 mmn
in diameter, and c) spreading variant up to 5 mm in diameter.
Any or all types may be recovered on primary isolation. No
aerobic growth should be seen.
To observe growth, examine a wet mount of the broth
under phase microscopy. The organism is a small, slender,
straight sided rod with rounded ends and with a rapid darting
motility. Motility is best observed in young cultures.
The cells do not Gram stain well using traditional
procedures. To obtain the best results, use a basic fuchsin
counterstain in place of the safranin.
Storage at liquid nitrogen temperatures, with 10%
glycerol as the cryoprotectant, is recommended for long-tern
preservation.
ANAEROBIC CONDITIONS:
Anaerobic conditions for transfer may be obtained by
either of the following:
* Use of an anaerobic gas chamber, or
* Placement of test tubes under a gassing cannula system
hooked to anaerobic gas.
Anaerobic conditions for incubation may be obtained by
any of the following:
* Loose screw caps on test tubes in anaerobic chamber,
* Loose screw caps on test tubes in an activated anaerobic
gas pack jar, or
* Use of sterile butyl rubber stoppers on test tubes so that
an anaerobic gas headspace is retained.
conditions have not been met and oxidation has occurred.
Medium should be discarded.
Additional information on this culture is available on the
ATCC web site at www.ajtcc.og.
REFERENCES:
I. Vandamme P, Falsen E, Rossau R, Hoste B, Segers P,
Tytgat R, De Ley J. Revision of Campylobacter,
Helicobacter, and Wolinella taxonomy: emendation of
generic descriptions and proposal of Arcobacter gen.
nov.. Int. J. Syst. Bacteriol. 41:88-103, 1991. PubMed:
1704793
2. Tanner AC, Badger S, Lai CH, Listgarten MA, Visconti
RA, Socransky SS. Wolinella gen. nov., Wolinella
succinogenes (Vibrio succinogenes Wolin et al.) comb.
nov., and description of Bacteroides gracilr sp. nov.,
Wolinella recta sp. nov., Campylobacter concism sp.
nov.. and Eikenella corrodemr from humans with
periodontal disease. Int. J. Syst. Bacteriol. 31:432-445,
1981.
3. Badger SJ, Tanner AC. Serological studies of Bacterotdes
gracilis, Campylobacter concisma, Wolinella recta, and
Eikenella corrodens, all from humans with periodontal
disease. Int. J. Syst. Bacteriol. 31:446-451, 1981.
4. Lai CH, Listgarten MA, Tanner AC, Socransky SS.
Ultrastructures of Bacteroides gracilis, Campylobacter
concisus, Wolinella recta, and Fikenella corrodens, all
from humans with periodontal disease. Int. J. Syst.
Bacteriol. 31:465-475, 1981.
5. Guillot E, Mouton C. PCR-DNA probe assays for
identification and detection of Prevotella intermedia
sensu stricto and Prevotella nigrescens. J. Clin.
Microbiol. 35:1876-1882, 1997. PubMed: 9196214
6. Marchesi JR, Sato T, Weightman AJ, Martin TA, Fry JC,
Hiom SJ, Wade WG. Design and evaluation of useful
bacterium-specific PCR primers that amplify genes
coding for bacterial 16S rRNA. Appl. Environ. Microbiol.
64:795-799, 1998. PubMed: 9464425
7. Wang B, Kraig E, Kolodrubetz D. A new member of the
S-layer protein family: characterization of the crs gene
from Campylobacrer rectus. Infect. Immun. 66:1521-
1526, 1998. PubMed: 9529076
O ATCC, 2005. All rights reserved.
ATCC' is a registered trademark of the American Type Culture
Collection.
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Always use freshly prepared pr-reduced media or pre-
reduced media that has been previously prepared but stored
under anaerobic conditions. Resazurin in the media is a color
indicator for anaerobic conditions. Observance of pink color in
-tedium before use or during incubation shows anaerobic
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COLLECTION OF BACTERIA
.iTCC NUMBER: 10953"
ORGANISM: Fusobacterum nudcleatum subsp.
polymorphum
Type strain. Deposited as Fmobacterium polymorphum.
CITATION OF STRAIN:
If use of this strain results in a scientific publication it
should be cited in that manuscript in the following manner:
Fusobacterinm mndeatum subsp. polymorphum ATCC*
10953".
ATCC MEDIUM:
#1490 Broth: Modified Chopped Meat Medium (see below)
For solid medium, add 2% agar.
Ground beef (fat-free), 500.0 g
Distilled water, 1.0 L
IN NaOH, 25.0 ml
Mix meatm water and NaOH and bring to a boil with stirring
Cool to room temperature, skim fat from swuface and filter,
retainig both meat paricles and filtrate To fdiltrate, add
sficient distilled water to restore volume to 1.0 L. To this
fdlarte, add.
seypticase (BD 211921), 30.0 g
Least extract, 5.0 g
KzHPO4, 5.0 g
0.025% Resazurin, 4.0 ml
Agar (if desired), 20.0 g
Boll and cool medium under 80% Nrl0% HrO1% CO0, and
add:
Cysteine HCI'H3O, 0.5 g
Hemin Solution (see below)l 10.0 ml
Vitamin K, Solution (see below), 0.2 ml
Adjst medIum for fmal pH 7.0. Anaerobically dispense 7 ml
medium Into tubes containing meat particles (1 part meat to 5
parts flu•o mder the same gas phase.
Vitamin K, Solution:
Vitamin K,, 0.15 mi
95% Ethanol, 30.0
Store solution in brown bottle under refrigeration
Discard afer one montk
Hemin Solution:
Hemin, 50.0 mg
1N NaOH, 1.0 ml
Distilled water to 100.0 ml
Autoclae at 121C for 15 minutes.
CONDITIONS:
Temperature: 37*C
Atmosphere: Anaerobic gas mixture,
80% NrlO0% COrlO%6 H2
BIOSAFETY LEVEL: 1
Appropriate safety procedures should always be used with
this material. Laboratory safety is discussed in the following
publication: Biosafety in Microbiological and Biomedical
Laboratories, 4th ed. HHS Publication No. (CDC) 93-3395.
U.S. Department of Health and Human Services, Centers for
Disease Control and Prevention. Washington DC: U.S.
Govennent Printing Office; 1999. The entire text is available
online at www.cdc.gov/od/ohs/biosftv/bmbl4/bmbl4toc.hm.
ATCC WARRANTY:
The viability of ATCC products is warranted for 30 days
from the date of shipment If you feel there is a problem with
this product, contact Technical Services by phone at 800-638-
6597 or 703-365-2700 or by e-mail at tech(iatc.org. Or you
may contact your local distributr.
DISCLAIMERS:
This product is intended for laboratory research purposes
only. It is not intended for use in humans.
While ATCC uses reasonable efforts to include accurate
and up-to-date information on this product sheet, ATCC makes
no warranties or representations as to its accuracy. Citations
from scientific literature and patents are provided for
informational purposes only. ATCC does not warrant that such
information has been confirmed to be accurate.
This product is sent with the condition that you are
responsible for its safe storage, handling and use. ATCC is not
liable for any damages or injuries arising fom receipt and/or
use of this product. While reasonable effort is made to insure
authenticity and reliability of strains on deposit, ATCC is not
liable for damages arising from the misidentification or
misrepresentation of cultures.
Please see the enclosed Material Transfer Agreement
(MTA) for further details regarding the use of this product
The MTA is also available on our Web site at ww.w yatsrg.
PROPAGATION PROCEDURE:
1. Open vial according to enclosed instructions.
2. Under anaerobic conditions, withdraw 0.5 ml of
recommended broth from a single test tube (5 to 6 mi) and
rehydrate the entire vial contents.
3. Aseptically transfer this aliquot back into the broth tube.
A slant and a pre-reduced blood plate may also be
inoculated with 0.1 ml each of the cell suspension. An
Amerlan Type Culture Collecton
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aerobic blood plate may also be streaked to check for
purity.
4. Incubate tubes and plate under anaerobic conditions at
370C. Incubate blood plate aerobically at 370C.
5. In 24 to 48 hours, growth is evident by turbidity in the
broth. On agar surfaces, colonies are circular, with an
entire margin, convex elevation, smooth surface and
mottled appearance. No hemolysis occurs on blood agar.
No growth should occur on the blood agar plate incubated
aerobically. Cells are long thin rods with pointed ends.
ANAEROBIC CONDITIONS:
Anaerobic conditions for transfer may be obtained by
either of the following:
* Use of an anaerobic gas chamber, or
* Placement of test tubes under a gassing cannula system
hooked to anaerobic gas.
Anaerobic conditions for incubation may be obtained by
any of the following:
* Loose screw caps on test tubes in anaerobic chamber,
* Loose screw caps on test tubes in an activated anaerobic
gas pack jar, or
* Use of sterile butyl rubber stoppers on test tubes so that
an anaerobic gas headspace is retained.
.0OTES:
Always use freshly prepared pre-reduced media or pre-
reduced media that has been previously prepared but stored
under anaerobic conditions. Resazurin in the media is a color
indicator for anaerobic conditions. Observance of pink color in
medium before use or during incubation shows anaerobic
conditions have not been met and oxidation has occurred.
Medium should be discarded.
Additional information on this culture is available on the
ATCC web site at www.atcc~org.
REFERENCES:
I. Ohio J. Sci. 53:141, 1955.
2. Dzink IL, Sheenan MT, Socransky SS. Proposal of three
subspecies of Fusobacierium nucleatum Knorr 1922:
Fusobacterium nucleatum subsp. nudeatum subsp. nov.,
comb. nov.; Fusobacterium nucleatum subsp.
polymorphum subsp. nov., nom. rev., comb. nov.; and
Fusobacterium nucleatum subsp. vincentii subsp. nov.,
nom. rev., comb. nov.. Int. J. Syst. Bacteriol. 40:74-78,
1990. PubMed: 2223601
3. Takada H, Ogawa T, Yoshimura F, Otsuka K, Kokeguchi
S, Kato K, Umemoto T, Kotani S. Immunobiological
activities of a porin fraction isolated from Fusobacaerium
nucleatam ATCC 10953. Infect. Immun. 56:855-863,
1988. PubMed: 2831155
4. Robrish SA, Thompson J. Na+ requirement for glutamate-
dependent sugar transport by Fusobacterum nucleatum
ATCC 10953. Curr. Microbiol. 19:329-334, 1989.
5. Guillot E, Mouton C. PCR-DNA probe assays for
identification and detection of Prevotel Intermedia
sensu stricto and Prevotella nigrescens. J. Clin.
Microbiol. 35:1876-1882, 1997. PubMed: 9196214
6. Morris ML, Andrews RH, Rogers AH. Investigations of
the taxonomy and systematics of Fusobacterium
nucleatum using allozyme electrophoresis. Int. J. Syst.
Bacteriol. 47:103-110, 1997. PubMed: 8995811
0 ATCC, 2005. All rights reserved.
ATCC& is a registered trademark of the American Type Culture
Collection.
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COLLECTION OF BACTERIA
ATCC NUMBER: 25611 '
ORGANISM: Prevotella intermedia
Type strain. Subgroup 4197; group A. Deposited as
Bacteroides melaninogenlcus subsp. intermedius.
CITATION OF STRAIN:
If use of this strain results in a scientific publication it
should be cited in that manuscript in the following manner:
Prevotella intermedia ATCC e 25611"'.
ATCC MEDIUM:
#1490 Broth: Modified Chopped Meat Medium
For solid medium, add 2% agar to formula below.
Ground beef (fat-free), 500.0 g
Distilled water, 1.0 L
INNaOH, 25.0 ml
Mib meat. water and NaOH and bring to a boil with stirring.
Cool to room temperarare, skim fat from surface and filter,
retaining both mear particles and fltrate. To filtrate, add
suficient distilled water to restore volume to 1.0 L To this
fdirare, add.
Trypticase (BD 211921), 30.0 g
Yeast extract, 5.0 g
k4HPO,, 5.0 g
0.025% Resaurin, 4.0 ml
Agar (if desred), 20.0 g
Boil and cool medium under 80% N2, 10% Hyf 10% COz and
add-
Cysteine HCIH2O, 0.5 g
Hemin Solution (see below), 10.0 ml
Vitamin K, Solution (see below), 0.2 ml
Ad)jst medium for final pH 7.0 Anaerobically dispense 7 ml
into tubes containing meat particles (I part meat to 5 parts
fluir under the same gas phare.
Vitamin KI Solution:
Vitamin KI, 0.15 ml
95% Ethanol, 30.0 mil
Store solution in brown bottle under refrigeration.
Discard fter one month
Hemin Solution:
Hemin, 50.0 amg
N NaOH, 1.0 ml
Distilled water to 100.0 ml
Autoclave at 12IC for 15 minutes.
CONDITIONS:
Temperature: 37*C
Atmosphere: Anaerobic gas mixture
80% Nrl-(o COr10% H2
BIOSAFETY LEVEL: 2
Appropriate safety procedures should always be used with
this material. Laboratory safety is discussed in the following
publication: Biosafety in Microbiological and Biomedical
Laboratories, 4th ed. HHS Publication No. (CDC) 93-8395.
U.S. Department of Health and Human Services, Centers for
Disease Control and Prevention. Washington DC: U.S.
Goveranment Printing Office; 1999. The entire text is available
online at www.edc.gov/odloha/biotv/bmblibmbl4t.oc .
ATCC WARRANTY:
The viability of ATCC products is warranted for 30 days
from the date of shipment. If you feel there is a problem with
this product, contact Technical Services by phone at 800-638-
6597 or 703-365-2700 or by e-mail at techatc.ora. Or you
may contact your local distributor.
DISCLAIMERS:
This product is intended for laboratory research purposes
only. It is not intended for use in humans.
While ATCC uses reasonable efforts to include accurate
and up-to-date information on this product sheet, ATCC makes
no warranties or representations as to its accuracy. Citations
from scientific literature and patents are provided for
informational purposes only. ATCC does not warrant that such
information has been confirmed to be accurate.
This product is sent with the condition that you are
responsible for its safe storage, handling, and use. ATCC is not
liable for any damages or injuries arising from receipt and/or
use of this product. While reasonable effort is made to insure
authenticity and reliability of strains on deposit, ATCC is not
liable for damages arising from the misidentification or
misrepresentation of cultures.
Please see the enclosed Material Transfer Agreement
(MTA) for further details regarding the use of this product.
The MTA is also available on our Web site at www.atcc.or.
PROPAGATION PROCEDURE:
I. Open vial according to enclosed instructions.
2. Under anaerobic conditions, withdraw 0.5 ml of the
recommended broth from a single test tube (5 to 6 ml) and
rehydrate the entire vial contents.
3. Aseptically transfer this aliquot back into the broth.
Additional tubes may be inoculated with 0.5 ml each from
the suspension. Also, 0.1 ml may be inoculated onto a
slant. Streak several blood plates to check for colonial
morphology and purity.
Aarloan Type Culft ColeClon
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4. Incubate tubes under an anaerobic atmosphere at 37"C.
Incubate one agar plate anaerobically for colony
formation, and one aerobically for aerobic contamination
check.
5. Within 24-48 hours, growth should be evident by
turbidity in the broth. On ager surfaces, colonies are
pinpoint, circular, entire, convex, and black pigmented, no
hemolysis. No growth should occur on the blood agar
plate incubated aerobically.
ANAEROBIC CONDITIONS:
Anaerobic conditions for transfer may be obtained by
either of the following:
* Use of an anaerobic gas chamber, or
* Placement of test tubes under a gassing cannula system
hooked to anaerobic gas.
Anaerobic conditions for incubation may be obtained by
any of the following:
* Loose screw caps on test tubes in anaerobic chamber,
* Loose screw caps on test tubes in an activated anaerobic
gas pack jar, or
* Use of sterile butyl rubber stoppers on test tubes so that
an anaerobic gas headspace is retained.
gingivalis and Prevotella intermedla. J. Bacteriol.
179:620-626, 1997. PubMed: 9006012
6. Guillot E. Mouton C. PCR-DNA probe assays for
identification and detection of Prevoeella inermedia
sensu stricto and Prevotella nigrescens. J. Clin.
Microbiol. 35:1876-1882, 1997. PubMed: 9196214
7. Iki K, Kawahara K, Sawamura S, Arakaki R, Sakuta T,
Sugiyama A, Tamura H, Sueda T, Hamada S, Takada H.
A novel component different from endotoxin extracted
from Prevotela intermedia ATCC 25611 activates
lymphod cells from C3H/HeJ mice and gingival
fibroblasts from humans. Infect. Immun. 65:4531-4538,
1997. PubMed: 9353030
8. Teles R, Wang CY, Stashenko P. Increased susceptibility
of RAG-2 SCID mice to dissemination of endodontic
infections. Infect. Immun. 65:3781-3787, 1997. PubMed:
9284152
9. Skerman VB, McGowan V, Sneath PH. Approved lists of
bacterial names. Int. J. Syst. Bacteriol. 30:225-420, 1980.
0 ATCC, 2005. All rights reserved.




This organism requires the addition of Vitamin K, and
Jemin to the media to obtain growth. See media section for
details.
Always use freshly prepared pre-reduced media or pre-
reduced media that has been previously prepared but stored
under anaerobic conditions. Resazurin in the media is a color
indicator for anaerobic conditions. Observance of pink color in
medium before use or during incubation shows anaerobic
conditions have not been met and oxidation has occurred.
Medium should be discarded.
Additional information on this culture is available on the
ATCC web site at www.tcc.gr.
REFERENCES:
I. Bergey's Manual Syst. Bacteriol. 1:622, 1984.
2. Johnson JL, Holdeman LV. Bacteroides intermedius
comb. nov. and descriptions of Bacteroides corporis sp.
nov. and Bacteroides levil sp. nov.. Int. J. Syst. Bacteriol.
33:15-25,1983.
3. Shah HN, Collins DM. Prevotella, a new genus to include
Bacteroides melaninogenicus and related species formerly
classified in the genus Bacteroide.. Int. J. Syst. Bacteriol.
40:205-208, 1990. PubMed: 2223612
4. Nakazawa F, Zambon JJ, Reynolds HS, Genco RI.
Serological studies of oral Bacteroides intermedius.
Infect. Immun. 56:1647-1651, 1988. PubMed: 3131249
5. Tompkins GR, Wood DP, Birchmeier KR. Detection and
comparison of specific hemin binding by Porphyromonas
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Type strain. Deposited as Bacteroide gngivalis. Quality
control strain for bioMerieux Vitek products. Purified
gaomile DNA of this strain is available a ATCC 33277D".
CITATION OF STRAIN:
If use of this strain results in a scientific publication it
should be cited in that manuscript in the following manner.
Porpkyromonas ginghvalis ATCC' 33277".
ATCC MEDIUM:
#1490 Broth: Modified Chopped Meat Medium (see below)
For solid medium, add 2% agar to formula below.
Ground beef (fa-free), 500.0 g
Distilled water, 1.0 L
IN NaOH, 25.0 ml
AMa meat water and NaOH and bring to a boil with stirring.
Cool to room temperature, skin fat from surface and filter,
retaining both meat partidcles and filtrate. To filtrae, add
srlJcient distilled water to restore volume to 1.0 L To this
fillrate, add:
rypticas (BD 21921), 30.0
Yeast extract, 5.0 g
K(HPO 4, 5.0 g
0.025% Resazurin, 4.0 ml
Agar (fdesired), 20.0 g
Boil and cool medium under 80% Nr10% HrI-O% CO. and
add.
Cysteine HCI HO, 0.5 g
Hemin Solution (see bdow), 10.0 ml
Vitamin K, Solution (see below), 0.2 ml
Ap medium for fmal pH 7.0. Anarrobically dispense
7 ml medum into tubae cantaining measparticles (I part meat
to 5 parts fld) under the same gas phase.
Vitamin Kt Solution:
Vitamin Ki, 0.15 ml
95% Ethanol, 30.0
Store solution in brown botle under refrigeration.
Discard fter one month.
Hemin Solution:
Hemin, 50.0 mg
IN NaOH. 1.0 ml
Distilled water to 100.0 ml
Autoclave at 121°Cfor 15 minutes.
CONDITIONS:
Temperature: 370C
Atmosphere: Anaerobic gas mixture,
80% Nl-10%C 2 -10%Hz
BIOSAFETY LEVEL: 2
Appropriate safety procedures should always be used with
this material. Laboratory safety is discussed in the following
publication: Biosafety in Microbiological and Biomedical
Labormaories. 4th ed HHS Publication No. (CDC) 93-8395.
U.S. Department of Health and Human Services, Centers for
Disease Control and Prevention. Washington DC: U.S.
Government Printing Office; 1999. The entire text is available
online at www.cdc.v./odlohs/iosity/bmbl4bmbl4toc.hm.
ATCC WARRANTY:
The viability of ATCC products is warranted for 30 days
from the date of shipment. If you feel there is a problem with
this product, contact Technical Services by phone at 800-638-
6597 or 703-365-2700 or by e-mail at tech(a~ atc.org Or you
may contact your local distributor.
DISCLAIMERS:
This product is intended for laboratory research purposes
only. It is not intended for use in humans.
While ATCC uses reasonable efforts to include accurate
and up-to-date information on this product sheeta ATCC makes
no warranties or representations as to its accuracy. Citations
from scientific literature and patents are provided for
informational purposes only. ATCC does not warrant that such
information has been confirmed to be accurate.
This product is sent with the condition that you are
responsible for its safe storage, handling, and use. ATCC is not
liable for any damages or injuries arising from receipt and/or
use of this product. While reasonable effort is made to insure
authenticity and reliability of strains on deposit, ATCC is not
liable for damages arising from the misidentification or
misrepresentation ofcultures.
Please see the enclosed Material Transfer Agreement
(MTA) for further details regarding the use of this product.
The MTA is also available on our Web site at www.atcc.org.
PROPAGATION PROCEDURE:
1. Open vial according to enclosed instructions.
2. Under anaerobic conditions, withdraw 0.5 ml of
recommended broth from a single test tube (5 to 6 mi) and
rehydrate the entire vial contents.
3. Aseptically transfer this aliquot back into the broth tube.
A slant and a pre-reduced blood plate may also be
inoculated with 0.1 ml each of the cell suspension. An
Amerlean Type Culture Collection
P.O. Box 1549






Or contact your local distributor.
__
A/T C C0 Product Information Sheet for ATCC& 33277"
aerobic blood plate may also be streaked to check for
purity.
4. Incubate tubes and plate under anaerobic conditions at
37*C. Incubate blood plate aerobically at 370C.
5. Within 48 hours, growth should be evident by turbidity in
the broth.
ANAEROBIC CONDITIONS:
Anaerobic conditions for transfer may be obtained by
either of the following:
* Use of an anaerobic gas chamber, or
* Placement of test tubes under a gassing cannula system
hooked to anaerobic gas.
Anaerobic conditions for incubation may be obtained by
any of the following:
* Loose screw caps on test tubes in anaerobic chamber,
* Loose screw caps on test tubes in an activated anaerobic
gas pack jar, or
* Use of sterile butyl rubber stoppers on test tubes so that
an anaerobic gas headspace is retained.
NOTES:
Always use fleshly prepared pre-reduced media or pre-
reduced media that has been previously prepared but stored
hider anaerobic conditions. Resazurin in the media is a color
indicator for anaerobic conditions. Observance of pink color in
medium before use or during incubation shows anaerobic
conditions have not been met and oxidation has occurred.
Medium should be discarded.
On agar surfaces, colonies are pinpoint, circular, entire,
and convex with no hemolysis. No growth should occur on the
blood agar plate incubated aerobically.
Additional information on this culture is available on the
ATCC web site at www.atcc.org.
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